Curet Pharmaceuticals Pvt Ltd
About Curet Pharmaceuticals Pvt Ltd
Data last updated:
Curet Pharmaceuticals Pvt Ltd is a private limited company based in Chandigarh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH1994PTC015380. Its GSTIN is 07AACCC3391D1ZY (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.58 Lakh. It is led by directors Jatinder Kapoor (Whole-Time Director) and Dharmesh Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 154 – 155 1st Floor Sector 17 – C, Chandigarh, India – 160017.
As per the financials filed for FY 2025, the company reported a revenue of ₹14 Lakh. For the same year it recorded a net profit of ₹4,560 (net margin 0.3%) and EBITDA of ₹20,322 (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Curet Pharmaceuticals Pvt Ltd's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 154 – 155 1st Floor Sector 17 – C, Chandigarh, India – 160017
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Curet Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curet Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curet Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Curet Pharmaceuticals Pvt Ltd
FY 2025 filings availableCuret Pharmaceuticals Pvt Ltd reported revenue of ₹14 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,322 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,560 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curet Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Curet Pharmaceuticals Pvt Ltd
Curet Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatinder Kapoor | Whole-Time Director | 26 Jun 2000 | 26 Years 3 Months | Current |
| Dharmesh Kapoor | Director | 23 Jul 2018 | 8 Years 2 Months | Current |
Peer comparison
Curet Pharmaceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kamsom Pharmaceuticals Private Limited | ₹14.03 Lakh (FY 2022) | -81.0% | Rohtak, Haryana, India | |||
| Trumount Pharmaceuticals Private Limited | ₹14.02 Lakh (FY 2025) | -94.0% | Baddi, Himachal Pradesh, India | |||
| Accore Pharmaceuticals Private Limited | ₹14.01 Lakh (FY 2022) | 201.0% | Hyderabad, Telangana, India | |||
| Curet Pharmaceuticals Pvt Ltdthis company | ₹14 Lakh (FY 2025) | ₹4,560 | 0.3% | Chandigarh, India | ||
| Gaurisi Pharmaceuticals Private Limited | ₹13.97 Lakh (FY 2022) | 1161.0% | Lucknow, Uttar Pradesh, India | |||
| Dbrmd Pharmaceuticals Private Limited | ₹13.95 Lakh (FY 2018) | Kolkata, West Bengal, India |
To see the full peer comparison of Curet Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Curet Pharmaceuticals Pvt Ltd is audited by RAJESH MEHRA & ASOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH MEHRA & ASOCIATES | FY 2017 | 009725N |
Shareholding
The shareholding of Curet Pharmaceuticals Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Curet Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Curet Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curet Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Curet Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCC3391D1ZY | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Curet Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Curet Pharmaceuticals Pvt Ltd has 10 board changes on record since 2000: 6 appointments and 4 cessations. The latest: Ranjana Kapoor ceased to be Whole-Time Director on 11 Aug 2018.
1 earlier event is in the company report.
Frequently asked questions
Curet Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 November 1994 (32+ years old) and is registered under CIN U24232CH1994PTC015380.
Curet Pharmaceuticals has 2 current directors:
- Jatinder Kapoor - Whole-Time Director
- Dharmesh Kapoor - Director
The latest financial statements of Curet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Curet Pharmaceuticals is 07AACCC3391D1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Curet Pharmaceuticals is U24232CH1994PTC015380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curet Pharmaceuticals was incorporated on 30 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Curet Pharmaceuticals by revenue are Kamsom Pharmaceuticals Private Limited, Trumount Pharmaceuticals Private Limited, Accore Pharmaceuticals Private Limited, Gaurisi Pharmaceuticals Private Limited, Dbrmd Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ranjana Kapoor ceased to be Whole-Time Director on 11 Aug 2018. Roopa Kapoor ceased to be Whole-Time Director on 11 Aug 2018. Saroj Dilbagi ceased to be Whole-Time Director on 11 Aug 2018. Curet Pharmaceuticals has 10 board changes on record in total.
The registered office of Curet Pharmaceuticals is at SCO 154 – 155 1st Floor Sector 17 – C, Chandigarh, India – 160017.
Curet Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Curet Pharmaceuticals is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.